openPR Logo
Press release

US Generic Drug Market 2019-2024 - Analysis, Forecasts & Opportunities by Segment, Therapy Area, Drug Delivery, Distribution Channel and Key Players

02-22-2019 10:09 AM CET | Health & Medicine

Press release from: IMARC Group

US Generic Drug Market 2019-2024 - Analysis, Forecasts & Opportunities by Segment, Therapy Area, Drug Delivery, Distribution Chann

US Generic Drug Market 2019-2024 - Analysis, Forecasts & Opportunities by Segment, Therapy Area, Drug Delivery, Distribution Chann

In the upcoming years, the US generic drug market is anticipated to experience strong growth. The increasing cases of lifestyle diseases, initiatives undertaken by the US Government and upcoming patent expirations of branded drugs will contribute to the growth of the market.

Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=567&flag=B

According to the latest report by IMARC Group, titled “US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the US generic drug market reached a value of nearly US$ 104 Billion in 2018, growing at a CAGR of more than 12% during 2011-2018. Generic drugs refer to bioequivalents of brand name drugs which offer identical pharmacological effects in terms of risk, dosage, safety, side-effect, intended use and route of administration. They are available at low rates as their manufacturing requires minimal resources for drug approval, research, promotion and packaging. Currently, a rise in the demand for generic drugs has been witnessed in the United States owing to the prevalence of chronic diseases, reducing life expectancy, high mortality rates and aging population in the region. Additionally, the Government is emphasizing on the use of generics as they assist in reducing the overall healthcare expenditure in the country. It has also established the Office of Generic Drugs (OGD) to ensure that people have easy access to safe and affordable drugs.

Browse full repot with complete TOC: https://www.imarcgroup.com/us-generics-market

Market Trends:

Since decades, the US population has been dependent on fast food, frozen items and packaged food products that are high in calories and sodium. This trend can be accredited to the easy availability of these products, long working hours, high per capita income and expanding fast-food chains. These factors, coupled with the sedentary lifestyle led by the population, have increased the cases of heart diseases, cancer, diabetes, obesity, and Alzheimer’s and Parkinson’s disease, thereby creating a strong demand for generic drugs. Moreover, the Government is promoting the uptake of these drugs as a cost-containment measure which is providing a thrust to the generics market. Further, several branded drugs are anticipated to lose their patent protection in the upcoming years which is expected to offer remunerative opportunities to the generic drugs manufacturers. By 2024, the market value is projected to exceed US$ 190 Billion, expanding at a CAGR of around 11% during 2019-2024.

Market Segmentation:

Market Breakup by Segment:

1. Unbranded Generics

2. Branded Generics

On the basis of segments, the market has been bifurcated into unbranded and branded generics. At present, unbranded generics dominate the market, holding the largest share.

Market Breakup by Therapy Area:

1. CNS

2. Cardiovascular

3. Dermatology

4. Genitourinary/Hormonal

5. Respiratory

6. Rheumatology

7. Diabetes

8. Oncology

9. Others

Based on therapy areas, the market has been classified into CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, oncology and others.

Market Breakup by Drug Delivery:

1. Oral

2. Injectables

3. Dermal/Topical

4. Inhalers

The market has also been segregated on the basis of drug deliveries which include oral, injectables, dermal/topical and inhalers. Currently, oral drug delivery accounts for the majority of the market share as it offers advantages like dosage accuracy, convenience and ease of adherence to the medication schedule.

Market Breakup by Distribution Channel:

1. Retail Pharmacies

2. Hospital Pharmacies

Based on distribution channels, the market has been categorized into retail and hospital pharmacies. Amongst these, hospital pharmacies exhibit a clear dominance in the market.

competitive landscape:

The competitive landscape of the market has been examined with some of the key players being Teva, Sandoz, Sun Pharma, Mylan, Actavis, Par Pharmaceuticals, Endo Pharmaceuticals, Lupin Pharmaceuticals, Dr. Reddy’s and Hospira.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us

IMARC Group
309 2nd St, Brooklyn, NY 11215, USA
Website: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Generic Drug Market 2019-2024 - Analysis, Forecasts & Opportunities by Segment, Therapy Area, Drug Delivery, Distribution Channel and Key Players here

News-ID: 1609570 • Views:

More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insights
India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market. Market Size & Future Growth Potential: The India seafood
India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025-2033
India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025: Base Year: 2024 Historical Years: 2019-2024 Forecast Years: 2025-2033 Market Size in 2024: USD 2.50 Billion Market Size in 2033: USD 5.90 Billion Market Growth Rate (CAGR) 2025-2033: 10.03% How Big is the India Mutual Funds Industry? The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033. Request
Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Expanding at a CAGR of 8.09%
Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview: The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC
Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, Project Economics
Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay. IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase